Roche (OTCMKTS:RHHBY) Share Price Passes Above 50-Day Moving Average – Should You Sell?

Roche Holding AG (OTCMKTS:RHHBY) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $52.90 and traded as high as $55.73. Roche shares last traded at $55.5250, with a volume of 3,983,664 shares trading hands.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on RHHBY shares. Morgan Stanley upgraded shares of Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 target price on the stock in a research report on Friday, August 7th. HSBC downgraded shares of Roche from a “buy” rating to a “hold” rating in a research report on Monday, July 6th. Finally, Zacks Research downgraded shares of Roche from a “hold” rating to a “strong sell” rating in a research note on Tuesday, July 14th. Five equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $60.00.

Roche Stock Performance

The business’s 50-day moving average is $53.06 and its two-hundred day moving average is $52.92. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.38 and a quick ratio of 1.12.

Institutional Trading of Roche

Several hedge funds and other institutional investors have recently made changes to their positions in the company. McIlrath & Eck LLC purchased a new position in Roche during the first quarter worth about $39,000. Oakworth Capital Inc. increased its position in Roche by 20.8% during the 4th quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock worth $86,000 after purchasing an additional 285 shares during the period. Atlas Capital Advisors Inc. purchased a new position in shares of Roche during the 4th quarter worth approximately $192,000. Pinnacle Wealth Management Advisory Group LLC acquired a new stake in shares of Roche in the 1st quarter valued at approximately $208,000. Finally, Enterprise Financial Services Corp lifted its holdings in shares of Roche by 6.6% in the 1st quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock valued at $277,000 after buying an additional 345 shares during the period.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.